Is LifeMD Inc Preferred Series A (LFMDP) overvalued? · rev $212.5M
LifeMD Inc Preferred Series A (LFMDP) is a health information services company listed on US.
This page asks whether LifeMD Inc Preferred Series A (LFMDP) looks expensive on cached numbers — not a short thesis.
Latest reported LFMDP revenue for 2024-12-31 was $212.5M. Net income was -$18.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. LFMDP currently screens at market cap $0.
LFMDP currently screens at market cap $0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next LFMDP 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the LFMDP stock page for the full model, not this heading.
Not investment advice.